Skip to main content
Clinical Trials/NCT00877435
NCT00877435CompletedNot Applicable

Prize Reinforcement Contingency Management for Cocaine Dependence: a 24-week Randomized Controlled Trial

University Hospital, Basel, Switzerland4 sites in 1 country60 target enrollmentStarted: September 1, 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
60
Locations
4
Primary Endpoint
retention in treatment, cocaine abstinence

Study Overview

Brief Summary

The purpose of this study is to determine whether prize-based contingency management (prizeCM) combined with cognitive behavioral therapy (CBT) is more effective in the treatment of of cocaine-dependent patients compared to CBT only. Patients were randomized to prizeCM + CBT (experimental group) or to CBT (control group) an treated over 24 weeks. It is the first trial of this type in Europe.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • cocaine dependence, aged 18 or older, other dependences

Exclusion Criteria

  • severe somatic, brain, or psychiatric disease, attention deficit disorders with medication methylphenidate

Outcomes

Primary Outcomes

retention in treatment, cocaine abstinence

Time Frame: 24 weeks

cocaine abstinence: at least 3 consecutive weeks of cocaine abstinence, the maximum number of weeks of continous abstinence and proportions of cocaine-free urine samples during the entire 24-week and at 6-month follow-up.

Secondary Outcomes

  • patients' satisfaction with the therapy, clinical measures(24 weeks)

Investigators

Sponsor
University Hospital, Basel, Switzerland
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sylvie Petitjean

Dr. phil

University Hospital, Basel, Switzerland

Study Sites (4)

Loading locations...

Similar Trials